Patent · US Expired

Supplemented fibrin matrix delivery systems

US7229959B1 · kind B1 · utility

36Cited by
69References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 7, 1995
Grant dateJun 12, 2007
Priority date
Expiry dateJun 7, 2015

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2533/56
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention provides supplemented and unsupplemented tissue sealants as well as methods for their production and use thereof. Disclosed are tissue sealants supplemented with at least one antibody. The composition may be further supplemented with, for example, one or more analgesics, antimicrobial compositions, anticoagulants, antiproliferatives, anti-inflammatory compounds, cytokines, cytotoxins, drugs, growth factors, interferons, hormones, lipids, demineralized bone or bone morphogenetic proteins, cartilage inducing factors, oligonucleotides polymers, polysaccharides, polypeptides, protease inhibitors, vasoconstrictors or vasodilators, vitamins, minerals, stabilizers and the like.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.